German Accelerator Life Sciences ("GALS") helps young German life science companies succeed in the global market. GALS provides individualized and highly flexible services, tailored towards the specific needs and objectives of startups and emerging companies in the life sciences.Experienced mentors and consultants work with the participating teams to establish networks of potential clients, partners, and investors. Located in Cambridge, Massachusetts, GALS offers a 3-to-12-month program that is open to companies from the following segments:
- Digital Health
- Diagnostics
- Medical Devices
- Reagents and Services
- Platform Technologies
- Therapeutics.
This program is an opportunity for startups and emerging companies to refine and validate their business cases in the Boston life science ecosystem, and to get ready to enter the US market with their products and services. Ideally, applicants have already gained traction, generated revenue, and shown potential for category leadership in a large, global market.
GALS is now accepting applications from qualified companies - Application Deadline for Q1 and Q2 2016: November 30, 2015!
